Technology

AI-powered technology enabling early detection of serious health diseases

 
 
Jim Kean, the CEO of Molecular You joins eHealth Radio and the Health News and Technology Channels to discuss how their AI-powered technology is enabling early detection of serious health diseases even before symptoms appear.
Listen to interview with host Eric Michaels and guest Jim Kean discuss the following:
What particular problems does Molecular You’s solution solve?
What inspired you to feel passionate about this cause?
How important is AI to what you do?
How do you think this will change the healthcare world?
What would you recommend to listeners who want to be more proactive about their long-term health today?
Jim Kean is the CEO of Molecular You. He is a senior technology executive with an innovative career focused on making healthcare easier by pioneering disruptive consumer-oriented health and wellness digital experiences. The consistent theme: creating user delight, loyalty, and retention while fundamentally re-engineering the cost of delivery.
As the former CEO of WellnessFx™, he provided affordable consumer health services, earning recognition as the 2012 Innovative Company of the Year. Kean also spearheaded online health communities as President of Sapient Health Network, which merged with WebMD in 1999. After WebMD, Jim served as Entrepreneur in Residence with Alloy Ventures of Palo Alto. With a rich history of scaling companies, he continues to lead groundbreaking ventures, most recently as CEO of Molecular You.
 
Website: https://www.molecularyou.com
People also listened to this: Making It Through Your First Holiday Season After a Divorce

A Breakthrough Solution for Treating Central Nervous System Disorders Including Strokes and Cluster Headaches

 
Dr. Peter Bonutti, M.D., a surgeon, inventor, author, professor, consultant, and entrepreneur with over 30 years of experience joins eHealth Radio and the Health News and Technology Channels.
Listen to interview with host Eric Michaels and guest Dr. Peter Bonutti discuss the following:
Bonnutti Technologies has a track record of identifying problems and has more than 500 patents—tell me about your latest breakthrough with Releave which is being used by 700 patients already.
What is the problem you are solving?
How many people suffer from cluster headaches and neuro disorders?
What is the science behind Releave? How does Releave work? Is it an implant and a device?
There is a lot of talk about chip implants…not approved by the FDA. You are approved and have patients, how hard was the process?
How are you funded and who is the team behind the project?
How can potential patients and medical professionals learn more about Realeve?
Dr. Peter Bonutti, M.D. is a surgeon, inventor, author, professor, consultant, and entrepreneur with over 30 years of experience. He is the founder of Bonutti Research, a medical device incubator that has developed products and technology used around the world, including UVCeed, and maintains his clinical and surgical practice, focusing on adult knee and hip arthroplasty and integration of robotics into surgical procedures.
Dr. Bonutti is a pioneer in Minimally Invasive Surgery, has over 500 patents and applications, more than 700 licenses and multiple FDA-approved products to date. Major corporations leveraging his technology include Hitachi, Medtronic, Kyphon, Covidien, US Surgical, Biomet, Arthrocare, Synthes, Zimmer/Biomet and Stryker. He is a prolific speaker, lecturing internationally, and has trained over 100 surgeons on his surgical techniques.
In his career, Dr. Bonutti has received more than a dozen industry honors and awards for his achievements. Dr. Bonutti earned his medical degree at University of Cincinnati College of Medicine and completed his Orthopaedic Surgery Residency at Cleveland Clinic Foundation with international fellowships in Canada, Australia, and Austria.
Website: https://www.realeve.net
People also listened to this: The Psychology of Asking for Forgiveness and Forgiving

A need in the US marketplace for international medical offerings

 
John Mooney President and Co-Founder, International Medical Lasers, a medical industry leader in sourcing the world's highest quality surgical devices for the U.S. medical marketplace & Paolo Salvadeo, CEO, DEKA M.E.L.A., that has more than three decades of international medical laser experience joins eHealth Radio and the Health News and Technology Channels.
Listen to interview with host Eric Michaels and guests John Mooney & Paolo Salvadeo discuss the following:
Mr. Salvadeo:  This is interesting to see the DEKA Italian laser product here in the U.S.  Can you tell us what market need the laser solves for U.S. patients?


Mr. Mooney:  Your company, International Medical Laser, specializes in global medical technology.  Can you tell us about your company saw a need in the US marketplace for international medical offerings?


Mr. Salvadeo:   I saw in your LinkedIn profile that you have been honored as a Knight of the Order of Merit of the Italian Republic - Master of Work.  Can you explain how someone earns such a prestigious honor ?
Mr. Mooney:  you are in a unique position to evaluate U.S. versus global medical technology offerings.  Can you share some differences - or similarities - between domestic and international medical equipment - either in the design, how patient need is met or other criteria?
Mr. Salvadeo:  Can you share some of your humanitarian work with us?  We understand you undertook an initiative that engaged the Pope?

IML sources state-of-the-art medical devices from around the globe, and makes them available in the U.S. We work with top tier international manufacturers to provide innovative yet practical medical technology solutions for hospitals, surgical centers, and other institutions. Through its strong network of dealers, IML supports medical teams as they address patient care in hospitals, surgery centers and clinics across the U.S.
IML Links: Website: https://imlasers.com  LinkedIn: https://linkedin.com/company/international-medical-lasers  Facebook: https://facebook.com/IMLasersUS Twitter: https://twitter.com/IMLasers
DEKA Links: Website: https://dekalaser.com/usa Facebook: https://facebook.com/DEKALaser.Official Instagram: https://instagram.com/dekalaser_official LinkedIn: https://linkedin.com/company/deka-laser Youtube: https://youtube.com/user/DEKALASERTV 

Biotechnology company developing therapeutic candidates targeting drug-resistant and devastating cancers using ferroptosis

 
 
Randy Milby, the Chief Executive Officer and Chairman of Hillstream BioPharma, a biotechnology company developing therapeutic candidates targeting drug-resistant and devastating cancers using ferroptosis, an emerging new anti-cancer mechanism resulting in iron mediated cell death, and immuno-oncology targeted novel biologics joins eHealth Radio and the Cancer Information & Health News Channels.
Listen to interview with host Eric Michaels and guest Randy Milby discuss the following:
Please tell us a bit about your background and Hillstream BioPharma.
What developments are currently in Hillstream’s pipeline?
How does ferroptosis-targeted therapy differentiate from other cancer treatments currently available or under development?
Why is it important to Hillstream to develop drug resistant therapeutics for cancers with few treatment options?
What advice can you share with industry peers, key opinion leaders, or anyone pursuing R&D in the biotechnology space?
Looking ahead, what exciting advances do you think are on the horizon for Hillstream?
Mr. Milby previously served as Chief Executive Officer and Member of the Board of Directors at CorMedix, a publicly traded biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of inflammatory and infectious diseases. He is a seasoned executive who led the increase in market capitalization from $3M to a peak of $350M of Cormedix while improving the company’s financial position with capital raises from equity markets. He oversaw efforts to gain CE Market approval of Neutrolin® in the European Union and held increasing roles of responsibility at Goldman Sachs and Dupont Merck prior in his career.
 
Website: https://hillstreambio.com 
Social Media Links: Facebook: https://facebook.com/HillstreamBioPharma  Linkedin: https://linkedin.com/company/hillstream-biopharma  Twitter: https://twitter.com/HillstreamB 
People also listened to this: Checkable Medical: Revolutionizing Home Healthcare and Telemedicine

Why time is of the essence for innovation to improve mental health outcomes

 
 
John Letter the CEO of Proem Behavioral Health, formerly nView Health, the developer of the evidence-based clinical workflow software engine that helps providers triage patients and produce better mental health outcomes joins eHealth Radio and the Health News and Mental Health Channels.
Listen to interview with host Eric Michaels and guest John Letter discuss the following:
Could you share with me what Proem Behavioral Health does - how does your solution, work and overall industry impact reach researchers, healthcare providers and behavioral health and addiction specialists?
As we all know and hear frequently on the news, mental health is a critical area needing innovation due to the epidemic proportions of mental health issues and conditions. Why do you think taking not only new tech approaches to address this epidemic are needed, but also a reframe on mental health itself as being easily treated by providers? 
Beyond the stigma that can exist or lack of awareness among patients as well as some medical providers not being equipped till now to address mental health challenges, what do you think is needed that is tied to technology to help more people get the treatment they need?
As someone who is in a business leadership position within the healthcare industry more broadly, what do you recommend to healthcare innovations who may be entrepreneurs, or even innovation minded teams working within larger companies to make an impact that’s meaningful?
What are some areas of focus your team at Proem is focused on for the rest of this year that you hope will have made a positive change in the field by 2024?
John Letter is CEO of Proem Behavioral Health, formerly nView Health, developer of the evidence-based clinical workflow software engine that helps providers triage patients and produce better mental health outcomes. He is an experienced healthcare executive serving most recently as the President and COO of a successful population health company in the sleep health space.
John works tirelessly to help teams achieve sustainable growth while over-delivering on customer promises each day. At Proem, John is responsible for overall strategic direction, working alongside an incredible team focused on building digital health tools to help providers get the right answers, diagnoses and outcomes for their patients the first time. John and his wife reside in Atlanta and have two grown children.
Website: https://www.proemhealth.com
People also listened to this: How divorce and separation can drive someone to harm and even death

How To Peer Into The Future Using Technology For Seniors

 
 
Ryan McEniff, owner of WellAware Care, a fall detection and remote monitoring service for seniors living at home or in senior communities like assisted or independent living communities joins eHealth and the Senior Care and Technology Channels.
Listen to interview with host Eric Michaels and guest Ryan McEniff discuss the following:
What is WellAware Care service?
How did you get involved in this company?
How is it different from other fall detection companies like PERs?
Why is this important for seniors to have?
What is your data showing you with falls?
Ryan McEniff is the owner of Minute Women Home Care, a private home care company as well as WellAware Care. He is active in his community with the National Aging In Place Council as well as the host of his own podcast, The Caregiver's Toolbox.
Website: https://wellawarecare.com
Social Media Links: Facebook: https://facebook.com/wellawarecareLinkedin: https://linkedin.com/company/wellaware-care

The Role of FibroScan® in the Multi-Modal Management of Patients with Chronic Liver Disease

 
 
Dr. Tejas Joshi, Director of Liver Diseases and Assistant Professor at Marshall University School of Medicine in Huntington, WV joins eHealth Radio and the Liver Health and Health News Channels.
Listen to interview with host Eric Michaels and guest Dr. Tejas Joshi discuss the following:
Could you give an overview of what FibroScan is, and discuss why you decided to implement this into your practice?
How do you feel that the use of FibroScan has benefitted your practice and your unique patient population?
We’ve covered considerable benefits of this tool for patients. What is the value of FibroScan to the provider?
Which different practitioners could be involved in the liver management algorithm?
What advice would you give to those practitioners interested in implementing FibroScan into their practice?
Dr. Tejas Joshi is a New Jersey native who completed Hepatology and Liver transplantation training at Baylor University in Houston Texas prior to settling in Huntington, WV. He is now practicing Hepatology in West Virginia caring for unique patients in Appalachia with chronic liver diseases. He is also board certified in obesity medicine and utilizes that to care for his patients with metabolic syndrome associated liver disease. His clinical research interests include liver cancer, cirrhosis, fatty liver disease, obesity medicine, autoimmune liver disease, viral hepatitis and liver transplant outcomes.
Website: https://echosens.com
Social Media Links: Facebook: facebook.com/fibroscan.echosens  Linkedin: linkedin.com/company/echosens  Youtube: youtube.com/user/EchosensTV Twitter: twitter.com/Echosens

Fatty Liver Disease in Children: Prevalence, Evaluation, & Essential Tools

 
 
Dr. Alisha Mavis, a Pediatric Hepatologist at Duke University where she cares for pediatric patients with liver disease joins eHealth Radio and the Children's Health & Health News Channels.
Listen to interview with host Eric Michaels and guest Dr. Alisha Mavis discuss the following:
What is the prevalence of fatty liver disease in children, and who should we be screening?
When screening a child for fatty liver disease, what are some of the tools used to evaluate for the disease, and how is the diagnosis of pediatric fatty liver disease made?
What is the natural history of pediatric liver disease, and how does this differ from adult fatty liver disease?
What are the current recommendations for the treatment of pediatric fatty liver disease?
Are there other diseases associated with pediatric fatty liver disease?
As a pediatric hepatologist at Duke University, Dr. Mavis cares for children of all ages with a variety of liver diseases and patients with improperly functioning small bowel/intestinal failure requiring long-term nutritional support. She also cares for patients needing a liver and/or small bowel transplant.
One of the most common diseases seen in her clinic is non-alcoholic fatty liver disease (NAFLD), an increasing chronic condition in pediatrics that parallels the obesity epidemic. NAFLD and other chronic liver diseases place a significant burden on the child as well as the function of the family. Dr. Mavis’ goal is to do everything possible to support and encourage the child and family to maintain full participation across all aspects of life while managing their disease.
Her specific areas of interest are NAFLD, portal hypertension, liver transplant, and Fontan associated liver disease. Much of her research focuses on transplant outcomes and pediatric NAFLD, specifically relationships between early life changes and risk factors, nutritional aspects of fatty liver disease, and the impact of metabolic phenotype.
Website: https://echosens.com
Social Media Links: Facebook: facebook.com/fibroscan.echosens  Linkedin: linkedin.com/company/echosens  Youtube: youtube.com/user/EchosensTV Twitter: twitter.com/Echosens

HeartBeam: The First 12-lead medical grade heart attack detection that’s personal, portable, and easy-to-use

 
 
Branislav Vajdic, PhD, and the Chief Executive Officer and Founder of HeartBeam, Inc. joins eHealth Radio and the Heart Health and Health News Channels. HeartBeam is the first 12-lead medical grade heart attack detection that's personal, portable, and easy-to-use.
Listen to interview with host Eric Michaels and guest Dr. Branislav Vajdic discuss the following:
Please tell us about your background and why you launched HeartBeam. We'd love to hear more about how this device is being used for the first time outside of a medical setting, and what makes it different from what's currently available.
According to the American Heart Association, more people die from heart attacks during the last week of December than at any other time of the year.  How is HeartBeam positioned to slow this trend in terms of saving lives, trips to the hospitals, and how it helps people know if they are having a heart attack?
How will HeartBeam impact patients in remote areas and what does this mean for virtual medicine?
HeartBeam is being tested and in trials. Can you tell us a bit more? Where is HeartBeam currently being used? What has been the feedback from doctors and patients?
What's next for HeartBeam in 2023 and even in 2024?
Branislav Vajdic, PhD, Chief Executive Officer and Founder of HeartBeam, Inc, combines over 30 years of experience in technology development and senior management positions. Dr. Vajdic has been deeply involved with the development of HeartBeam’s technology to fit his vision for the Company.
Prior to HeartBeam from 2007 to 2010, Dr. Vajdic was CEO and Founder of NewCardio, a publicly traded company in the cardiovascular devices space. From 1984 to 2007, Dr. Vajdic was at Intel, where he held various senior management positions. At Intel, Dr. Vajdic was the designer of first Flash memory and two key inventions that enabled Flash as a product and led engineering groups responsible for Pentium 1 through Pentium 4 designs.
Dr. Vajdic was awarded two Intel Achievement Awards, the highest level of award for outstanding contributions to Intel. Dr. Vajdic is the author of numerous patents and publications in the fields of cardiovascular devices as well as chip design.
Website: https://www.heartbeam.com 
Social Media Links: Twitter: https://twitter.com/HeartBeamInc  LinkedIn: https://linkedin.com/company/heartbeam-inc 
People also listened to this: Mental Health for Teens with Ken Baum

Health Carousel: Keeping up with the digital trends while providing a personalized career experience

 
 
John Sebastian, the CEO of Health Carousel, one of the largest and fastest growing healthcare staffing and workforce management solutions in the US joins eHealth Radio and the Health Care and Health News Channels. John discusses the important balance of keeping up with the digital trends, continuing to provide a personalized career experience, and ensuring we are contributing to an ethical and sustainable workforce in healthcare.
Listen to interview with host Eric Michaels and guest John Sebastian discuss the following:
Can you tell us a bit about Health Carousel and the types of challenges the company offers solutions for?
Your company’s higher purpose is “Improving Lives and Making Healthcare Work Better”. Can you explain a little more about that and why it’s meaningful to you?
What trends are you starting to see & how do Health Carousel’s offerings stand out?
Health Carousel was recently recertified by the Alliance for Ethical International Recruitment Practices, can you talk a little bit about what that means for the company and the industry?
What’s next for Health Carousel?
John Sebastian is Chief Executive Officer at Health Carousel and has been with the Company for nearly 6 years. John previously served as President of Travel Nursing, Chief Digital officer, and Chief Marketing Officer .
Prior to Health Carousel, his career demonstrates broad business leadership across healthcare staffing, consumer products and industrial sales. He is an award-winning marketer and digital/e-commerce native, building successful businesses like Old Spice and Febreze.  He also has significant sales experience, leading sales organizations that work with top e-retailers, distributors, and healthcare customers.
John graduated from the University of Notre Dame with a BBA in accounting and earned an MBA from the University of Michigan’s Stephan M. Ross School of Business.
His main drive at Health Carousel is to deliver on the Company's purpose: to improve lives and make health care work better.
Website: https://www.healthcarousel.com 
Social Media Links: Facebook: https://facebook.com/HealthCarousel  TikTok: https://tiktok.com/discover/Health-carousel  Linkedin: https://linkedin.com/company/health-carousel  Instagram: https://instagram.com/healthcarousel 
People also listened to this: Charlie’s Table Gluten Free Pasta Invites Everyone to Eat Together